What We're Reading: Page 180
Industry reads hand-picked by our editors
Oct 07, 2020
-
STAT
Two female CRISPR scientists make history, winning Nobel Prize in chemistry for genome-editing discovery
-
Bloomberg
FDA Will Force Vaccine-Safety Disclosures If Makers Don't
-
Politico
HHS whistleblower Rick Bright resigns from government
-
Endpoints News
Roche joins AbbVie in stepping on Vertex's turf, betting $96M on an alternative CF approach
Oct 06, 2020
-
Reuters
Moderna vaccine trial contractors fail to enroll enough minorities, prompting slowdown
-
MarketWatch
Iovance's stock tumbles over questions about regulatory submission for melanoma drug
-
The Wall Street Journal
Covid-19 Vaccine Delivery Will Present Tough Challenge to Cargo Airlines
-
San Francisco Business Times
Startup from UC Berkeley CRISPR pioneer Jennifer Doudna lands ALS deal with Biogen
Oct 05, 2020
-
STAT
8 pressing questions about President Trump’s Covid-19 diagnosis
-
The Wall Street Journal
White House Takes Issue With FDA's Plans for Authorizing a Covid-19 Vaccine
-
Associated Press
3 win Nobel medicine prize for discovering hepatitis C virus
-
The New York Times
Clinical Trials Hit by Ransomware Attack on Health Tech Firm
Oct 02, 2020
-
Forbes
The Scientologist Billionaire Trying To Make A New Antibiotic
-
Science
FDA's own documents reveal agency's lax, slow, and secretive oversight of clinical research
-
STAT
Democrats press Amgen, Novartis, Mallinckrodt on pricing tactics
-
The Wall Street Journal
Telehealth Startup Hims Strikes Deal to Go Public Through SPAC
Oct 01, 2020
Sep 30, 2020
-
The Washington Post
7 former FDA commissioners: The Trump administration is undermining the credibility of the FDA
-
STAT
Catalyst loses lawsuit accusing the FDA of unfairly approving rival drug
-
Science
On the road with Operation Warp Speed, the U.S. COVID-19 vaccine effort
-
Endpoints News
Brent Saunders rides $400M wave to the top of the SPAC boom
Previous
